CanadaBis Capital Inc. (CANB.V)

CAD 0.04

(0.0%)

Net Debt Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual net debt in 2023 was 4.08 Million CAD , down -46.76% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly net debt in 2024 Q2 was 4.68 Million CAD , up 19.62% from previous quarter.
  • CanadaBis Capital Inc. reported annual net debt of 7.67 Million CAD in 2022, up 1.07% from previous year.
  • CanadaBis Capital Inc. reported annual net debt of 7.58 Million CAD in 2021, up 28.79% from previous year.
  • CanadaBis Capital Inc. reported quarterly net debt of 5.75 Million CAD for 2024 Q3, up 12.35% from previous quarter.
  • CanadaBis Capital Inc. reported quarterly net debt of 4.68 Million CAD for 2024 Q2, up 19.62% from previous quarter.

Annual Net Debt Chart of CanadaBis Capital Inc. (2023 - 2016)

Historical Annual Net Debt of CanadaBis Capital Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 4.08 Million CAD -46.76%
2022 7.67 Million CAD 1.07%
2021 7.58 Million CAD 28.79%
2020 5.89 Million CAD 275.95%
2019 1.56 Million CAD 548.69%
2018 -349.35 Thousand CAD 25.65%
2017 -469.89 Thousand CAD -213.26%
2016 -150 Thousand CAD 0.0%

Peer Net Debt Comparison of CanadaBis Capital Inc.

Name Net Debt Net Debt Difference
Aequus Pharmaceuticals Inc. 4.89 Million CAD 16.541%
Decibel Cannabis Company Inc. 37.48 Million CAD 89.104%
Delivra Health Brands Inc. -2.17 Million CAD 287.948%
Entourage Health Corp. 150.32 Million CAD 97.283%
Lifeist Wellness Inc. -188.12 Thousand CAD 2270.911%
Cannara Biotech Inc. 41.51 Million CAD 90.162%
Medicure Inc. -5.82 Million CAD 170.114%
PharmaCielo Ltd. 18.24 Million CAD 77.617%
Rubicon Organics Inc. 475.37 Thousand CAD -759.141%
BioSyent Inc. -3.68 Million CAD 210.832%
Voyageur Pharmaceuticals Ltd. 37.91 Thousand CAD -10671.763%